Submitted by Anonymous (not verified) on 9 November 2023 - 14:24
Human medicines European public assessment report (EPAR): Entyvio, vedolizumab, Colitis, Ulcerative;Crohn Disease, Date of authorisation: 22/05/2014, Revision: 25, Status: Authorised
Source:
